(lp0
S"MabVax Therapeutics Presents Two Posters at the American Association for ... PR Newswire  - Apr 5, 2017 SAN DIEGO, April 5, 2017 /PRNewswire/ -- MabVax Therapeutics Holdings, Inc. , a clinical-stage oncology drug development company, announces that it will present two posters in this morning's session featuring MVT-1075&nbsp;..."
p1
aS'MabVax Therapeutics Holdings, Inc. Has a Promising Pancreatic Cancer Treatment Equities.com - Oct 17, 2016 At the end of the second quarter this year, biotech junior MabVax Therapeutics Holdings, Inc.  enacted a 1-for-7.4 reverse split of its common stock and uplisted to the Nasdaq Capital Market.'
p2
aS'MabVax Therapeutics Holdings Inc. MBVX  Wall Street Journal - Oct 11, 2014 News MabVax Therapeutics Holdings Inc.MBVX. Significant News Only. 04/05/17; Press Release. MabVax Therapeutics Presents Two Posters at the American Association for Cancer Research  Annual Meeting on a Novel Radioimmunotherapy&nbsp;...'
p3
aS"MabVax Therapeutics Holdings, Inc.  Insider John David Hansen Sells ... Markets Daily - 15 hours ago MabVax Therapeutics Holdings logo MabVax Therapeutics Holdings, Inc.  insider John David Hansen sold 10,216 shares of the company's stock in a transaction on Wednesday, April 12th.The MabVax Therapeutics Holdings, Inc.  Insider John David Hansen Sells ... - Petro Global News 24"
p4
aS"Insider Trading Activity MabVax Therapeutics Holdings, Inc. (NASDAQ:MBVX ... Market Exclusive - Apr 7, 2017 John David Hansen , Insider of MabVax Therapeutics Holdings, Inc.  reportedly Sold 5,051 shares of the company's stock at an average price of 2.17 for a total transaction amount of $10,960.67 SEC Form.Mabvax Therapeutics Holdings, Inc.  Files Form 4 Insider Selling : John ... - Energy Index"
p5
aS'MabVax Therapeutics Holdings Hires Paul Resnick, MD as Chief Business Officer PR Newswire  - Apr 15, 2016 SAN DIEGO, April 15, 2016 /PRNewswire/ -- MabVax Therapeutics Holdings, Inc. , a clinical-stage oncology drug development company, announces the hiring of Paul Resnick, M.D.'
p6
aS"Insider Trading Activity MabVax Therapeutics Holdings, Inc. (NASDAQ:MBVX ... Market Exclusive - Apr 11, 2017 John David Hansen , Insider of MabVax Therapeutics Holdings, Inc.  reportedly Sold 1,476 shares of the company's stock at an average price of 2 for a total transaction amount of $2,952.00 SEC Form.Insider Selling: MabVax Therapeutics Holdings, Inc.  Insider Sells ... - Sports Perspectives"
p7
aS'Opko Spots Another Overlooked Opportunity In MabVax Therapeutics Seeking Alpha - Apr 8, 2015 Opko Health has a strong track record of identifying undervalued companies in which to invest. Opko most recently announced a strategic investment in MabVax Therapeutics which appears to present another such investment opportunity. MabVax has a&nbsp;...MabVax Therapeutics Catches Eye of Billionaire Investor Dr. Phillip Frost and ... - Marketwired '
p8
aS"MabVax Therapeutics Receives Stockholder Approval for Name Change and Reverse ... PR Newswire  - Sep 9, 2014 SAN DIEGO, Sept. 9, 2014 /PRNewswire/ -- MabVax Therapeutics Holdings, Inc. , a publicly-traded clinical stage cancer immunotherapy company, announced today that stockholders have approved a change in the Company's name from&nbsp;..."
p9
aS'Telik and MabVax Therapeutics Announce Definitive Merger Agreement PR Newswire  - May 12, 2014 Upon the closing of the transaction, Telik will be re-named MabVax Therapeutics Holdings, Inc. and will operate under the leadership of the MabVax management team with J. David Hansen, President and CEO of MabVax, serving as the President, CEO, and&nbsp;...Cancer Drug Developers MabVax, Telik Merge - Genetic Engineering NewsWhy Telik  Stock Is Soaring Today - TheStreet.com'
p10
a.